Fusion of FIG to the receptor tyrosine kinase ROS in a glioblastoma with an interstitial del(6)(q21q21) - Wikidata - awgldk - TriplyDB

Fusion of FIG to the receptor tyrosine kinase ROS in a glioblastoma with an interstitial del(6)(q21q21)

Fusion of FIG to the receptor tyrosine kinase ROS in a glioblastoma with an interstitial del(6)(q21q21)

http://www.wikidata.org/entity/Q28186796

about

Clinical use of crizotinib for the treatment of non-small cell lung cancer ALK and ROS1 as targeted therapy paradigms and clinical implications to overcome crizotinib resistance Will the Requirement by the US FDA to Simultaneously Co-Develop Companion Diagnostics (CDx) Delay the Approval of Receptor Tyrosine Kinase Inhibitors for RTK-Rearranged (ROS1-, RET-, AXL-, PDGFR-α-, NTRK1-) Non-Small Cell Lung Cancer Globally?ROS1 rearrangements define a unique molecular class of lung cancers.Crizotinib in ROS1-rearranged non-small-cell lung cancer.PF-06463922 is a potent and selective next-generation ROS1/ALK inhibitor capable of blocking crizotinib-resistant ROS1 mutations Testing for ROS1 in non-small cell lung cancer: a review with recommendations Targeted Therapies in Non-Small Cell Lung Cancer-Beyond EGFR and ALK From single-gene to multiplex analysis in lung cancer, challenges and accomplishments: a review of a single institution's experience.Breakpoint analysis of transcriptional and genomic profiles uncovers novel gene fusions spanning multiple human cancer types Spectrum of oncogenic driver mutations in lung adenocarcinomas from East Asian never smokers Transforming fusions of FGFR and TACC genes in human glioblastoma.Exploration of the gene fusion landscape of glioblastoma using transcriptome sequencing and copy number data Fluorescence in situ hybridization in surgical pathology: principles and applications.Survey of tyrosine kinase signaling reveals ROS kinase fusions in human cholangiocarcinoma Chromosome 3 anomalies investigated by genome wide SNP analysis of benign, low malignant potential and low grade ovarian serous tumours.Small molecule kinase inhibitors in glioblastoma: a systematic review of clinical studies.PDGFRA gene rearrangements are frequent genetic events in PDGFRA-amplified glioblastomas.Identifying and targeting ROS1 gene fusions in non-small cell lung cancer.Current concepts on the molecular pathology of non-small cell lung carcinoma.Molecular pathways: ROS1 fusion proteins in cancer.Activation of RAS family members confers resistance to ROS1 targeting drugs.Identification of KIF5B-RET and GOPC-ROS1 fusions in lung adenocarcinomas through a comprehensive mRNA-based screen for tyrosine kinase fusions.Mouse model for ROS1-rearranged lung cancer Oncogenic gene fusions in epithelial carcinomas Discovery and preclinical characterization of novel small molecule TRK and ROS1 tyrosine kinase inhibitors for the treatment of cancer and inflammation.Oxido-reductive regulation of vascular remodeling by receptor tyrosine kinase ROS1.Activated RET and ROS: two new driver mutations in lung adenocarcinoma.Tumor-specific mutations in low-frequency genes affect their functional properties.Lack of ROS1 Gene Rearrangement in Glioblastoma Multiforme Clinical and pathological significance of ROS1 expression in intrahepatic cholangiocarcinoma Novel roles for LIX1L in promoting cancer cell proliferation through ROS1-mediated LIX1L phosphorylation.Genetic and biochemical alterations in non-small cell lung cancer.KAOS: a new automated computational method for the identification of overexpressed genes.Deciphering the Key Features of Malignant Tumor Microenvironment for Anti-cancer Therapy Synergistic Effects of Crizotinib and Temozolomide in Experimental FIG-ROS1 Fusion-Positive Glioblastoma.PI3 kinase mutations and mutational load as poor prognostic markers in diffuse glioma patients Crizotinib for the treatment of ALK-rearranged non-small cell lung cancer: a success story to usher in the second decade of molecular targeted therapy in oncology ROS1 expression in invasive ductal carcinoma of the breast related to proliferation activity.Personalizing therapy in advanced non-small cell lung cancer

P2860

Q24630466-449783FD-3015-4E12-8BE1-9A57D8591557 Q26775347-A2D3D939-3D6D-4802-A0E9-794E66CCF348 Q27023383-98D9C974-2506-4AEC-B672-52AD2E80E1BA Q27851700-6F0C1EEB-3368-42CC-B4E7-778BC7B55BF6 Q27853075-183B1D01-10E4-4798-B061-34339D27AD93 Q27853138-EFB31654-3E83-494B-926B-D11203D5680E Q28070062-FBE612C6-1544-4137-96F5-673451933B35 Q28083446-1B6E70A6-8B26-43CA-84F5-59D7EEFE5F94 Q28385559-1E960FE6-0EED-415A-9905-943FC74860A2 Q28486949-6E7D2A26-6838-4381-9134-9A0CAE7754F2 Q28742090-B310E1E7-7CED-4083-B8A6-36A46F932477 Q30540467-93DFA911-A009-4AC0-8B9A-A385BD4A0EF8 Q30699293-F2066F6E-7E0C-4CB9-A8F9-50E6CEF709EB Q33593910-673FC594-25CE-41CF-8E62-CD86083CD550 Q33799157-AF27A3B8-A589-45A2-A99C-0DE785ED188E Q34097804-78E813BD-562C-4C41-B800-46A193855102 Q34132781-C75D5407-470B-4579-AB31-7B04E7C689DC Q34164924-54B5EAE0-5A4C-450E-B56E-91C277B684B3 Q34295696-FF200277-F030-408D-BC9E-F54F613B6E2A Q34310062-858562F7-1965-42ED-AD97-6A0DE03C7EBC Q34347504-CBCF1AEC-9567-4E30-A5B7-08D1E84C5724 Q34463388-3C7B34FC-5F1B-4DBA-A09D-C2693E202F41 Q34522899-E948C053-4C37-4F2F-930C-1D3BF1DFC2C0 Q34589721-7F7E046A-3A2A-43C4-B203-24554615E78B Q34949690-655507D6-3CBD-4AA7-A6AB-7CDDCB0C8A39 Q35080328-4D98E9F6-9C41-4D0C-A818-1CB73E378E6A Q35145481-34C32A67-01DF-418A-ADD6-7B1DCF4DB709 Q35206630-022FF8BC-7417-4CBE-A8D2-79AA9E9B1839 Q35621520-BAB8BCBB-2862-4F28-80DD-32CF2DD9254F Q35772397-4CD1B060-E659-44D6-8D89-2BCC2FCC4EBF Q35811132-6AB194B6-2C5B-4F57-87EC-297D591CA72D Q35999416-568A843E-4A60-4849-9F78-B28581E352A4 Q36184584-FCD349E3-2425-4A4E-94DC-2EBF562B0A90 Q36276385-62176FFD-B6FE-4ECD-912E-6809E0818803 Q36284940-2B0C3374-504F-4B7E-9A0F-03781949237A Q36341179-4E982640-C046-46F3-A4E7-A34A326E9FA2 Q36402259-10195DDD-CA34-432D-99AD-BE1166660409 Q36405628-9C47658E-863B-4CAA-A0DB-653105D230E2 Q36793176-0F714500-DF43-4C7E-8023-67F8FE07E980 Q36811453-A86B5698-F01B-4831-9F1D-CDF4EF3C09C0

P2860

Fusion of FIG to the receptor tyrosine kinase ROS in a glioblastoma with an interstitial del(6)(q21q21)

http://www.wikidata.org/entity/Q28186796

description

2003 nî lūn-bûn

@nan

2003 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

Fusion of FIG to the receptor ...... an interstitial del(6)(q21q21)

@ast

Fusion of FIG to the receptor ...... an interstitial del(6)(q21q21)

@en

Fusion of FIG to the receptor ...... an interstitial del(6)(q21q21)

@nl

type

label

Fusion of FIG to the receptor ...... an interstitial del(6)(q21q21)

@ast

Fusion of FIG to the receptor ...... an interstitial del(6)(q21q21)

@en

Fusion of FIG to the receptor ...... an interstitial del(6)(q21q21)

@nl

prefLabel

Fusion of FIG to the receptor ...... an interstitial del(6)(q21q21)

@ast

Fusion of FIG to the receptor ...... an interstitial del(6)(q21q21)

@en

Fusion of FIG to the receptor ...... an interstitial del(6)(q21q21)

@nl

P1433

Q28186796-6471A533-958B-45DE-9968-0A72922651CF

P1476

Q28186796-9251DF29-4580-4866-9E38-560ED532361D

P2093

Q28186796-3D91B0C2-39AC-4326-9238-7F3308909B17

Q28186796-3DE9B1B3-8E89-4713-B416-979B9C44E9E7

Q28186796-53F6A533-678A-465F-9EDE-13970B0236C1

Q28186796-A4CC551A-E559-4DD1-A2F1-56A625BB719E

Q28186796-B48643BA-525E-4F01-8E1E-EA0D460813B8

Q28186796-F5B4BA18-DFDF-44AF-AA60-1D8E6699848A

P304

Q28186796-3CF465C7-79DB-4172-9F6D-54610A8D924B

P31

Q28186796-10B30747-3022-4B06-8CD1-5CB210F022E2

P3181

Q28186796-CF8ACE04-DCDC-4A08-91FA-52FC58EFD2AA

P356

Q28186796-75042C3F-2F1E-413E-AB7F-CE575F0EC729

P407

Q28186796-2460ABC9-0142-4C68-BCA6-9335396DE69D

P433

Q28186796-FCC1F50A-5D94-497D-8DF0-F69CFB68E2DF

P478

Q28186796-B2E3AD73-149A-4323-B3DF-AD67B5227EC7

P50

Q28186796-C8BA7326-F9CB-4122-906B-1D4BB3C93E11

P577

Q28186796-50291728-BFCC-4E1C-91EF-F4A898831801

P698

Q28186796-301B6E90-CA51-47C9-B0C0-2FBEC32CD6CA

P3181

P356

P1433

Genes, Chromosomes and Cancer

P1476

Fusion of FIG to the receptor ...... an interstitial del(6)(q21q21)

@en

P2093

Alain Charest

http://www.w3.org/2001/XMLSchema#string

David Housman

http://www.w3.org/2001/XMLSchema#string

Elizabeth Preisinger

http://www.w3.org/2001/XMLSchema#string

Julie Park

http://www.w3.org/2001/XMLSchema#string

Keara Lane

http://www.w3.org/2001/XMLSchema#string

Kevin McMahon

http://www.w3.org/2001/XMLSchema#string

P304

58-71

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

4043257

http://www.w3.org/2001/XMLSchema#string

P356

10.1002/GCC.10207

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

37

http://www.w3.org/2001/XMLSchema#string

P50

P577

2003-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12661006

http://www.w3.org/2001/XMLSchema#string